(Q33286532)

25 July 2017

Development and optimization of high-throughput in vitro protein phosphatase screening assays (English)

1 reference

25 July 2017

John J Skoko

4

0 references

Paul Johnston

object named as

Paul A Johnston

series ordinal

2

0 references

John S. Lazo

series ordinal

7

object named as

John S Lazo

1 reference

25 July 2017

6

Tong Ying Shun

1 reference

25 July 2017

5

Sunita N Shinde

1 reference

25 July 2017

1

Marni Brisson Tierno

1 reference

25 July 2017

3

Caleb Foster

1 reference

PubMed ID

17546004

25 July 2017

language of work or name

1 reference

1 January 2007

1 reference

25 July 2017

1 reference

25 July 2017

2

1 reference

25 July 2017

5

1 reference

25 July 2017

1134-1144

1 reference

https://scigraph.springernature.com/pub.10.1038/nprot.2007.155

25 July 2017

0 references

cites work

NIH Molecular Libraries Initiative

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2007.155

Roadmap or roadkill: a pharmacologist's analysis of the NIH Molecular Libraries Initiative

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2007.155

Independent mechanistic inhibition of cdc25 phosphatases by a natural product caulibugulone

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2007.155

Discovery and characterization of novel small molecule inhibitors of human Cdc25B dual specificity phosphatase

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2007.155

Halenaquinone and xestoquinone derivatives, inhibitors of Cdc25B phosphatase from a Xestospongia sp.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2007.155

Four diterpenoid inhibitors of Cdc25B phosphatase from a marine anemone

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2007.155

Sesterterpenoids and an alkaloid from a Thorectandra sp. as inhibitors of the phosphatase Cdc25B.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2007.155

Biological evaluation of newly synthesized quinoline-5,8-quinones as Cdc25B inhibitors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2007.155

Identification of new Cdc25 dual specificity phosphatase inhibitors in a targeted small molecule array

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2007.155

Discovery and biological evaluation of a new family of potent inhibitors of the dual specificity protein phosphatase Cdc25.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2007.155

Identification of a potent and selective pharmacophore for Cdc25 dual specificity phosphatase inhibitors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2007.155

Novel benzofuran inhibitors of human mitogen-activated protein kinase phosphatase-1.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2007.155

CDC25 phosphatases as potential human oncogenes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2007.155

Cdc25 phosphatases and cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2007.155

Dual-specificity phosphatases as targets for antineoplastic agents

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2007.155

Dual specificity phosphatases: a gene family for control of MAP kinase function.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2007.155

Protein phosphatases and the regulation of mitogen-activated protein kinase signalling.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2007.155

Expression of mitogen-activated protein kinase phosphatase-1 (MKP-1) in primary human ovarian carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2007.155

Down-regulation of the dual-specificity phosphatase MKP-1 suppresses tumorigenicity of pancreatic cancer cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2007.155

Overexpression of mitogen-activated protein kinase phosphatases MKP1, MKP2 in human breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2007.155

Protein tyrosine phosphatase: enzymatic assays

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2007.155

Kinetic analysis of the catalytic domain of human cdc25B.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2007.155

Dual-specific Cdc25B phosphatase: in search of the catalytic acid

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2007.155

Redox regulation of protein tyrosine phosphatase 1B involves a sulphenyl-amide intermediate

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2007.155

Catalytic and chemical competence of regulation of cdc25 phosphatase by oxidation/reduction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2007.155

Catalytic inactivation of protein tyrosine phosphatase CD45 and protein tyrosine phosphatase 1B by polyaromatic quinones

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2007.155

A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2007.155

Redox regulation of Cdc25B by cell-active quinolinediones

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2007.155

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/NPROT.2007.155

1 reference

PubMed ID

17546004

Dimensions Publication ID

25 July 2017

0 references

1 reference

PubMed ID

17546004